Featured Posts

Support for fast-tracking new drugs into clinical trials for childhood acute leukemia

September 9, 2015

Children's Cancer Institute, under the direction of Principal Investigator, Professor Richard Lock, Head of the Leukaemia Biology Program, has been awarded close to US$2 million for 5 years under the Pediatric Preclinical Testing Consortium (PPTC), created by NCI to prioritise and fast-track new drugs into clinical trials in children with aggressive cancers.


Read more here: http://www.eurekalert.org/pub_releases/2015-09/ccia-sff090815.php

Please reload

I'm busy working on my blog posts. Watch this space!

Please reload

Recent Posts
Please reload